HS
KYMR icon

HighVista Strategies’s Kymera Therapeutics KYMR Stock Holding History

HighVista Strategies’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$315K Sell
3,785
-3,050
-45% -$242K 0.09% 153
2025
Q4 		$532K Sell
6,835
-8,893
-57% -$601K 0.14% 140
2025
Q3 		$890K Buy
+15,728
New +$709K 0.22% 129
2025
Q2 		– Sell
-8,733
Closed -$239K – 164
2025
Q1 		$239K Hold
8,733
– – 0.09% 143
2024
Q4 		$351K Sell
8,733
-4,010
-31% -$181K 0.13% 133
2024
Q3 		$603K Buy
+12,743
New +$563K 0.21% 112
2023
Q2 		– Sell
-25,530
Closed -$756K – 145
2023
Q1 		$756K Buy
+25,530
New +$823K 0.62% 54
2021
Q3 		– Sell
-18,587
Closed -$901K – 132
2021
Q2 		$901K Buy
18,587
+4,646
+33% +$202K 0.64% 27
2021
Q1 		$542K Sell
13,941
-3,176
-19% -$191K 0.4% 66
2020
Q4 		$1.06M Buy
+17,117
New +$835K 0.68% 24

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return